Seattle, November 24, 2014—PATH has named Dr. David Fleming as its vice president for Public Health Impact. Dr. Fleming will begin January 5, 2015 and be based in PATH’s Seattle headquarters.
Dr. Fleming will lead PATH’s Public Health Impact division, which houses the organization’s reproductive health, maternal and child health and nutrition, noncommunicable diseases, malaria control and elimination, and HIV/AIDS and tuberculosis programs. He also will oversee cross-programmatic collaboration at PATH, which seeks to maximize the impact of the organization’s work across the value chain in critical health areas, including maternal and neonatal health, diarrheal disease, and malaria.
“Dr. Fleming is a renowned leader in public health, domestically and globally, with valuable experience in bringing innovative health approaches to scale and forging collaborative partnerships,” said Steve Davis, president and CEO at PATH. “His expertise will help PATH accelerate progress toward our goal of tackling the world’s biggest health challenges.”
Making an impact locally and globally
Dr. Fleming has an impressive history in public and global health. He most recently served as the Director and Health Officer for Public Health—Seattle and King County (PHSKC) where he oversaw an office of 1400 employees, 28 sites, and a budget of over $300 million, serving a resident population of two million people.
“It’s an honor to take on the Public Health Impact portfolio at PATH,” said Dr. Fleming. “Public health—be it local or global—is about providing each of us with the best chance to be healthy. We live in a time of great opportunity for cross-border innovation and creativity, and PATH is perfectly positioned to catalyze this effort.”
Prior to his work at PHSKC, Dr. Fleming served as Director of Global Health Strategies at the Bill & Melinda Gates Foundation. There he had a grant portfolio of over a billion dollars in vaccine preventable disease, nutrition, maternal and child health, leadership, emergency relief, community health programs, and human resources and health information.
Dr. Fleming also worked as Deputy Director at the Center for Disease Control and Prevention (CDC), Science and Public Health, Deputy Administrator of U.S. Agency for Toxic Substances and Disease Registry (ATSDR).
Dedicated to advancing public health initiatives and education
Dr. Fleming is a clinical associate professor at the University of Washington School of Public Health. He completed his internal medicine residency at the University of Oregon Health Services Center, and his preventive medicine residency at the CDC.
Dr. Fleming currently serves on the boards of Global to Local Partnership and the Washington Global Health Alliance, both in Seattle, and the Trust for America’s Health in Washington DC. He sits on the Advisory Committee to the Director of the CDC and chairs the external advisory groups for the CDC’s Center for Global Health and also its Office of State, Tribal, Local, and Territorial Support.
His former global health board service includes Gavi, the Vaccine Alliance; the Global Alliance for Improved Nutrition (GAIN); the Health Metrics Network; and the Partnership for Maternal, Newborn and Child Health.
PATH is the leader in global health innovation. An international nonprofit organization, PATH saves lives and improves health, especially among women and children. Accelerating innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—PATH harnesses its entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, PATH takes innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. With these key partners, PATH delivers measurable results that disrupt the cycle of poor health. Learn more at www.path.org.